packageIdarucizumab

idarucizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Idarucizumab is an antidote used to treat haemorrhage in patients taking dabigatran. It is approved and authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q17630273 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:idarucizumab
ATC codes:V03AB37
DrugBank:DB09264
Wikidata:Q17630273

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown